Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England

Colin J. Crooks,Ayan Banerjea,James Jones,Caroline Chapman,Simon Oliver,Joe West,David J. Humes
DOI: https://doi.org/10.1111/apt.17632
2023-07-09
Abstract:Optimising FIT cut off may improve the diagnosis of colorectal cancer. Summary Background A faecal immunochemical tests (FIT) cut‐off of ≥10 μg Hb/g faeces is now recommended in the UK as a gateway to urgent (suspected cancer) investigation for colorectal cancer (CRC), based on an expected CRC risk threshold of 3%. Aims To quantify the risk of CRC at FIT cut‐offs by age, haemoglobin and platelet strata. Methods A cohort study of a symptomatic CRC pathway based on primary care FIT tests in Nottingham, UK (November 2017–2021) with 1‐year follow‐up. Heat maps showed the cumulative 1‐year CRC risk using Kaplan–Meier estimates. Results In total, 514 (1.5%) CRCs were diagnosed following 33,694 index FIT requests. Individuals with a FIT ≥ 10 μg Hb/g faeces had a >3% risk of CRC, except patients under the age of 40 years (CRC risk 1.45% [95% CI: 0.03%–2.86%]). Non‐anaemic patients with a FIT
pharmacology & pharmacy,gastroenterology & hepatology
What problem does this paper attempt to address?